Tempus

Tempus Overview

Tempus pioneers AI-enabled precision medicine, transforming healthcare for providers, life sciences organizations, and patients alike. This innovative platform harnesses the power of artificial intelligence and a vast dataset of multimodal data to accelerate the discovery of novel treatments, predict therapy effectiveness, identify crucial clinical trials, and diagnose diseases earlier. By integrating cutting-edge AI technologies, including generative AI and advanced digital pathology, Tempus significantly enhances patient care and streamlines drug development processes.

Tempus Key Features

• AI-Powered Precision Medicine: Accelerate novel target discovery, predict treatment efficacy, and identify potentially life-saving clinical trials with intelligent algorithms.
• Comprehensive Genomic Profiling: Utilize advanced genomic sequencing platforms, such as the xT platform, to uncover personalized therapeutic opportunities for cancer patients.
• Algorithmic Diagnostic Tests (Tempus ALGOS): Gain deeper diagnostic insights through AI-driven algorithmic models directly connected to various assays.
• Real-World Data & Analytics (Tempus Lens): Access and analyze a rich repository of multimodal real-world data, empowering both research and informed clinical decision-making.
• Clinical Trial Matching: Efficiently connect patients with suitable clinical trials, supporting providers and expediting drug development for biopharmaceutical partners.
• AI-Enabled Clinical Assistant (Tempus One & David): Leverage AI co-pilots like Tempus One and David, a generative AI assistant, to support healthcare providers and researchers, seamlessly integrating with Electronic Health Record (EHR) systems.
• Digital Pathology Solutions: Enhance diagnostic capabilities with AI-powered digital pathology analysis, further expanding the understanding of disease (e.g., through the Paige acquisition).
• AI-Driven Radiology Tools (Tempus Pixel): Apply specialized AI imaging analysis tools for evaluating therapy response and detecting anomalies across various organs, including lung, breast, cardio, and prostate.
• Cardiology AI (ECG-Low EF): Utilize FDA-cleared AI software to identify patients who may have a low left ventricular ejection fraction (LVEF) directly from ECG readings, facilitating earlier intervention.
• Care Pathway Solutions (Tempus NEXT): Help identify and close gaps in patient care within healthcare systems, ensuring optimized and efficient treatment pathways.
• Specialized Neurology & Psychiatry Tools: Access dedicated solutions like Tempus PRO and Notetaker, designed to support comprehensive care in complex neurological and psychiatric conditions.